"Executive Summary Oral Targeted Oncology Drug Market Market: Growth Trends and Share Breakdown
The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period
In this competitive marketplace, businesses are always in struggle to seek...
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031.
Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...
"Key Drivers Impacting Executive Summary First-in-Class Oncology Drug Market Market Size and Share
The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek